Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United Kingdom

Datos Bibliográficos

ID14908024
AutoresHolly D Mitchell, Holly Mitchell (0000-0002-6103-9975, autor de correspondencia), India Clancy, India L Clancy (UK Health Security Agency), Daniela De Angelis (0000-0001-6619-6112), Conor Egan (0000-0001-8834-9247), Ross J Harris, Ross Harris (0000-0003-3190-7281, UK Health Security Agency), Sharon Hutchinson (0000-0002-6891-6758), Pantelis Samartsidis (0000-0002-4491-9655), Peter Vickerman (0000-0002-8291-5890), Zoë Ward (0000-0002-0268-988X, University of Bristol), Alan Yeung (0000-0001-5226-3695), Mounia Zaouche, Matthew Hibbert (0000-0002-1759-455X, UK Health Security Agency), Beatrice Emmanouil (0000-0003-1223-5571, NHS Digital), Andrew Mcauley (0000-0002-6047-2400), Andrew T McAuley, Christopher Nugent, Chris Nugent (0000-0003-0882-7902, Public Health Agency), Josie Smith (0000-0002-7671-104X, Public Health Wales), Adelina Artenie (0000-0002-3085-2410), Monica Desai (0000-0001-8632-9808, UK Health Security Agency), Matthew Hickman (0000-0001-9864-459X)
Año2025
Volumen146
Páginas105059
Fecha de publicación2025-12-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2025.105059
PMID41242201
OpenAlexW4416293137
IdiomaEN
Referencias citadas54